Skip to main content
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. logo

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 603456 ISIN · CNE100001W36 LEI · 300300M9CIE6UX0BWZ27 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,744 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603456

About Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

https://www.jiuzhoupharma.com/

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and chemical intermediates. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing integrated services for small molecule drugs from preclinical stages through to commercial-scale production. Its core capabilities include complex chemical synthesis, process optimization, and the production of therapeutic components for central nervous system, cardiovascular, and anti-infective applications. The organization maintains a global supply chain, adhering to international quality standards such as those established by the FDA and EMA. By offering end-to-end technical solutions, it supports the development pipelines of innovative biotechnology and pharmaceutical firms worldwide.

Recent filings

Filing Released Lang Actions
浙江九洲药业股份有限公司关于公司收到化学原料药上市申请批准通知书的公告
Regulatory Filings
2026-06-02 Chinese
浙江九洲药业股份有限公司2026年第一次临时股东会会议资料
Proxy Solicitation & Information Statement Classification · 88% confidence The document is clearly the full meeting materials (agenda, notice, and detailed proposals) for the company’s 2026 first extraordinary shareholders’ meeting, including a resolution on share repurchase. This matches the definition of a Proxy Solicitation & Information Statement (materials sent to shareholders to provide information and request votes for meetings).
2026-05-27 Chinese
浙江九洲药业股份有限公司第八届董事会第二十一次会议决议公告
Board/Management Information Classification · 85% confidence The document is an announcement of the resolutions passed at the company’s board of directors meeting (the 21st meeting of the 8th Board). It contains board meeting details and voting results on share repurchase and convening an extraordinary shareholders’ meeting. This is a Board/Management Information filing (MANG).
2026-05-25 Chinese
浙江九洲药业股份有限公司关于召开2026年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a formal notice of the company’s 2026 first extraordinary general meeting, detailing meeting date, voting methods, agenda, shareholder registration and proxy instructions, and includes a proxy form attachment. It is not a full financial report or earnings release, but materials sent to shareholders to provide information and request votes. This fits the definition of a Proxy Solicitation & Information Statement.
2026-05-25 Chinese
浙江九洲药业股份有限公司关于以集中竞价交易方式回购公司股份的回购报告书
Transaction in Own Shares Classification · 97% confidence The document is a detailed announcement of the company’s share repurchase plan, including amounts, sources of funds, purposes (junk stock for equity incentives and capital reduction), repurchase method, price limits, duration, implementation procedures, and authorizations. This is not merely a publication notice or an interim/annual report; it is the company’s actual plan to transact in its own shares through centralized bidding. It therefore fits squarely under Transaction in Own Shares (POS).
2026-05-25 Chinese
浙江九洲药业股份有限公司2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a formal announcement of the resolutions passed and voting results at the company’s 2025 Annual General Meeting held on May 18, 2026. It lists each proposal, vote counts, and percentages, which aligns with a Declaration of Voting Results & Voting Rights Announcements.
2026-05-18 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.